672 related articles for article (PubMed ID: 35230695)
1. Multi-Omics Profiling of the Tumor Microenvironment.
Van Oekelen O; Laganà A
Adv Exp Med Biol; 2022; 1361():283-326. PubMed ID: 35230695
[TBL] [Abstract][Full Text] [Related]
2. Applications of Single-Cell Omics in Tumor Immunology.
Liu J; Qu S; Zhang T; Gao Y; Shi H; Song K; Chen W; Yin W
Front Immunol; 2021; 12():697412. PubMed ID: 34177965
[TBL] [Abstract][Full Text] [Related]
3. Applications of Single-Cell Omics to Dissect Tumor Microenvironment.
Guo T; Li W; Cai X
Front Genet; 2020; 11():548719. PubMed ID: 33329692
[TBL] [Abstract][Full Text] [Related]
4. Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology.
Finotello F; Eduati F
Front Oncol; 2018; 8():430. PubMed ID: 30345255
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment: barrier or opportunity towards effective cancer therapy.
Tiwari A; Trivedi R; Lin SY
J Biomed Sci; 2022 Oct; 29(1):83. PubMed ID: 36253762
[TBL] [Abstract][Full Text] [Related]
6. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
Front Immunol; 2021; 12():687975. PubMed ID: 34276676
[TBL] [Abstract][Full Text] [Related]
7. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
Ringquist R; Ghoshal D; Jain R; Roy K
Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
[TBL] [Abstract][Full Text] [Related]
8. Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology.
Arulraj T; Wang H; Ippolito A; Zhang S; Fertig EJ; Popel AS
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38557676
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Informatics for Tumor Microenvironment and Immunotherapy.
Tian J; Bai X; Quek C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674070
[TBL] [Abstract][Full Text] [Related]
10. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
11. The Single-Cell Level Perspective of the Tumor Microenvironment and Its Remodeling by CAR-T Cells.
Gao S; Sugimura R
Cancer Treat Res; 2022; 183():275-285. PubMed ID: 35551664
[TBL] [Abstract][Full Text] [Related]
12. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
13. From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment.
Koelsch N; Manjili MH
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569461
[TBL] [Abstract][Full Text] [Related]
14. The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy.
Lee JY; Kannan B; Lim BY; Li Z; Lim AH; Loh JW; Ko TK; Ng CC; Chan JY
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887186
[TBL] [Abstract][Full Text] [Related]
15. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy.
Jin Z; Sun X; Wang Y; Zhou C; Yang H; Zhou S
Front Immunol; 2022; 13():1018903. PubMed ID: 36300110
[TBL] [Abstract][Full Text] [Related]
16. Multimodal Molecular Imaging of the Tumour Microenvironment.
Foray C; Barca C; Backhaus P; Schelhaas S; Winkeler A; Viel T; Schäfers M; Grauer O; Jacobs AH; Zinnhardt B
Adv Exp Med Biol; 2020; 1225():71-87. PubMed ID: 32030648
[TBL] [Abstract][Full Text] [Related]
17. Expression of costimulatory and inhibitory receptors in FoxP3
Toker A; Ohashi PS
Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy.
Zhang Z; Chen L; Chen H; Zhao J; Li K; Sun J; Zhou M
EBioMedicine; 2022 Sep; 83():104207. PubMed ID: 35961204
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies.
Petitprez F; Vano YA; Becht E; Giraldo NA; de Reyniès A; Sautès-Fridman C; Fridman WH
Cancer Immunol Immunother; 2018 Jun; 67(6):981-988. PubMed ID: 28884365
[TBL] [Abstract][Full Text] [Related]
20. Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations.
Wong RL; Yu EY
Curr Treat Options Oncol; 2021 Jan; 22(2):13. PubMed ID: 33433743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
